SFI
NUVB icon

Susquehanna Fundamental Investments’s Nuvation Bio NUVB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-215,198
Closed -$572K – 1183
2024
Q4 		$572K Buy
+215,198
New +$554K 0.01% 831
2024
Q2 		$223K Buy
76,494
+54,762
+252% +$167K 0.01% 829
2024
Q1 		$79.1K Buy
+21,732
New +$41.7K ﹤0.01% 659

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Susquehanna Fundamental Investments's NUVB Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 215,198 shares — an estimated $572K sold.

Susquehanna Fundamental Investments first reported a position in NUVB in Q1 2024 and held it in 3 quarters. The position peaked at $572K in Q4 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Susquehanna Fundamental Investments reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 215,198 Nuvation Bio shares in Q1 2025, an estimated $572K.
  • Susquehanna Fundamental Investments first reported a position in Nuvation Bio in Q1 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Nuvation Bio position peaked at $572K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.